Zdrowie i gospodarka · 29/04/2021

FDA Seeks Public Comment on Clinical Trial Data Monitoring Committees

The Food and Drug Administration (FDA) is seeking public comment on its proposed collection of information related to clinical trial data monitoring committees, as required by the Paperwork Reduction Act of 1995. The public has 60 days to provide feedback on the proposed collection.